老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

247.69
+7.923.30%
成交量：126.01萬
成交額：3.09億
市值：163.95億
市盈率：19.31
高：249.01
開：239.70
低：237.23
收：239.77
52周最高：282.15
52周最低：186.05
股本：6,618.99萬
流通股本：6,553.95萬
量比：1.31
換手率：1.92%
股息：- -
股息率：- -
每股收益(TTM):12.83
每股收益(LYR):-4.4176
淨資產收益率：118.78%
總資產收益率：9.58%
市淨率：9.95
市盈率(LYR):-56.07

資料載入中...

總覽公司新聞資訊公告
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多